Subsequent Events	3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS *Hiring of Chief Medical Officer* On March 31, 2021, the Company entered into an employment agreement (the “Olivo Employment Agreement”), effective as of April 19, 2021, with Martin Sebastian Olivo, M.D. to become the Company’s Chief Medical Officer (“CMO”). In connection with the Olivo Employment Agreement, on April 19, 2021, Dr. Olivo was granted a stock option to purchase 120,000 shares of Common Stock. The option has an exercise price of $15.30 per share, a term of 10 years and vests 25% on the one-year anniversary of the date of grant and monthly for 36 months thereafter.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration